Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Sales (2016 - 2025)

Historic Return on Sales for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 0.13%.

  • Bio-Techne's Return on Sales rose 100.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.02%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.02% for FY2025, which is 900.0% down from last year.
  • Latest data reveals that Bio-Techne reported Return on Sales of 0.13% as of Q4 2025, which was up 100.0% from 0.13% recorded in Q3 2025.
  • Bio-Techne's Return on Sales' 5-year high stood at 44.87% during Q3 2022, with a 5-year trough of 0.22% in Q2 2025.
  • For the 5-year period, Bio-Techne's Return on Sales averaged around 2.37%, with its median value being 0.16% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 446000bps in 2022, then plummeted by -446800bps in 2023.
  • Over the past 5 years, Bio-Techne's Return on Sales (Quarter) stood at 0.27% in 2021, then crashed by -31bps to 0.18% in 2022, then crashed by -45bps to 0.1% in 2023, then increased by 17bps to 0.12% in 2024, then rose by 9bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q4 2025, 0.13% for Q3 2025, and 0.22% during Q2 2025.